Mode

qualitative/stocks/CME

CME Group Inc.

Symbol

CME

Sector

Financial Services

Country

US

Business Model

3.6/5

CME earns the large majority of revenue through per-contract clearing and transaction fees, with market data (surpassing $800M for the first time in FY2025) providing a contractual recurring layer. The exchange model exhibits exceptional operating leverage, sustaining an operating margin near 65% across FY2023-FY2025 as incremental volume flows through fixed infrastructure at near-zero marginal cost. The revenue base is predominantly U.S.-centric despite 46% of participants coming from outside the U.S. in FY2025, and volume-dependent fee income introduces more variability than a pure subscription model.

Revenue Predictability

3.75

Summary

Clearing and transaction fees (approximately 81% of FY2025 revenue) are volume-dependent rather than contractual; market data revenue, surpassing $800M in FY2025 for the first time, provides a genuinely recurring counterweight. CME delivered record revenue for four consecutive years through FY2022-FY2025, including resilient performance through the COVID volatility surge in FY2020 and the rate normalization cycle in FY2022.

Product Diversification

3.25

Summary

CME's product suite spans interest rates, equity index, energy, agricultural, metals, and FX derivatives, with no single product group commanding an overwhelming share of FY2025 volume. Interest rates remain the anchor franchise, but FY2025 commodities volumes grew alongside equity index, and a retail customer base that nearly quadrupled over the prior decade moderates segment concentration.

Geographic Diversification

2.75

Summary

While 46% of market participants came from outside the U.S. in FY2025, CME's exchange-traded contracts, regulatory framework, and clearing infrastructure are overwhelmingly U.S.-based, keeping revenue concentration in the U.S. well above 60%. Meaningful international participation improves somewhat, but does not offset the predominantly single-market revenue structure.

Scalability

4.25

Summary

CME's exchange infrastructure serves incremental contract volume at near-zero marginal cost, sustaining an operating margin near 65% across FY2023-FY2025. As total revenue expanded from $5.02B in FY2022 to $6.52B in FY2025, operating expenses (excluding license fees) remained relatively contained, with FY2026 guidance for that cost base at approximately $1.695B against a $6.5B revenue base.

Revenue Quality

3.75

Summary

Clearing and transaction fees are per-trade rather than subscription, but CME's contracts are mission-critical for institutional hedging of interest rates, commodities, and equities where no unregulated substitute exists at comparable scale. Market data licenses, surpassing $800M in FY2025, add a contractual recurring tier; the combination sits above the exchange-sector average given the non-discretionary nature of institutional risk-management demand.

Competitive Advantages

4.1/5

CME's moat rests on three reinforcing pillars: network-driven liquidity concentration, deep clearing infrastructure lock-in, and annual pricing leverage exercised without volume loss. Holding over 90% of U.S. interest rate derivatives market share, CME is the venue counterparties must use for dollar-rate hedging, which compounds both the network and switching cost advantages. Innovation and brand contribute modestly. The collective result is one of the widest competitive moats in U.S. financial infrastructure.

Pricing Power

4.25

Summary

Switching Costs

4.50

Summary

Network Effects

4.75

Summary

Brand Strength

3.50

Summary

Innovation Barrier

3.25

Summary

Full analysis requires login

Sign in to unlock competitive advantages, management quality, risk assessment, and conclusions.

Sign in to continue

_ Report generated by Moatware Analysis AI

This analysis is for informational purposes only and does not constitute a buy or sell recommendation or financial advice. Do your own research before investing.